Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:56 PM
Ignite Modification Date: 2025-12-25 @ 2:38 PM
NCT ID: NCT00371150
Description: None
Frequency Threshold: 5
Time Frame: 52 Weeks
Study: NCT00371150
Study Brief: Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Entecavir (ETV) Entecavir tablets, Oral, 0.5 mg, once daily, up to 48 weeks (Includes 6 participants of the Hispanic cohort) None None 4 46 21 46 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
RENAL CELL CARCINOMA SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA 14.0 View
PYREXIA SYSTEMATIC_ASSESSMENT General disorders MedDRA 14.0 View
ANGINA PECTORIS SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 14.0 View
ASCITES SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 14.0 View
BLOOD GLUCOSE ABNORMAL SYSTEMATIC_ASSESSMENT Investigations MedDRA 14.0 View
HEADACHE SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 14.0 View
LEUKOCYTOSIS SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 14.0 View
LOBAR PNEUMONIA SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 14.0 View
PNEUMONIA SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 14.0 View
ALANINE AMINOTRANSFERASE INCREASED SYSTEMATIC_ASSESSMENT Investigations MedDRA 14.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
ABDOMINAL PAIN SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 14.0 View
DIARRHOEA SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 14.0 View
FATIGUE SYSTEMATIC_ASSESSMENT General disorders MedDRA 14.0 View
MYALGIA SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 14.0 View
NASOPHARYNGITIS SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 14.0 View
INFLUENZA SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 14.0 View
NAUSEA SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 14.0 View
SOMNOLENCE SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 14.0 View
PYREXIA SYSTEMATIC_ASSESSMENT General disorders MedDRA 14.0 View
BACK PAIN SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 14.0 View
HEADACHE SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 14.0 View
URINARY TRACT INFECTION SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 14.0 View